Detalhe da pesquisa
1.
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Cell
; 183(2): 347-362.e24, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064988
2.
Morphological and phenotypic analyses of the human placenta using whole mount immunofluorescence.
Biol Reprod
; 90(5): 110, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24648400
3.
A universal MHCII technology platform to characterize antigen-specific CD4+ T cells.
Cell Rep Methods
; 3(1): 100388, 2023 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814840
4.
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer.
Cancer Cell
; 40(9): 1010-1026.e11, 2022 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027916
5.
Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1.
Cell Rep Med
; 1(8): 100141, 2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33294862